A Ph 2 Trial With an Oral Tableted COVID-19 Vaccine
Trial details
- Registry ID
- NCT05067933
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as Oral Tableted Ad5 COVID-19 Vaccine
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Ph 2 Trial With an Oral Tableted COVID-19 VaccineNCT05067933 | Vaxart | Phase 2 | Terminated | 2022-06-10Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |